alpha-methylserotonin has been researched along with Chronic Disease in 1 studies
alpha-methylserotonin: potent agonist at M & D receptors of serotonin; RN given refers to parent cpd
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasaki, M | 1 |
| Obata, H | 1 |
| Saito, S | 1 |
| Goto, F | 1 |
1 other study available for alpha-methylserotonin and Chronic Disease
| Article | Year |
|---|---|
Antinociception with intrathecal alpha-methyl-5-hydroxytryptamine, a 5-hydroxytryptamine 2A/2C receptor agonist, in two rat models of sustained pain.
Topics: Animals; Behavior, Animal; Chronic Disease; Dose-Response Relationship, Drug; Formaldehyde; GABA-A R | 2003 |